Supernus Pharmaceuticals
SUPN
SUPN
209 hedge funds and large institutions have $1.07B invested in Supernus Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 80 increasing their positions, 71 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $1.2B → $1.07B (-$129M)
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
65% less call options, than puts
Call options by funds: $595K | Put options by funds: $1.71M
Holders
209
Holding in Top 10
1
Calls
$595K
Puts
$1.71M
Top Buyers
| 1 | +$20.7M | |
| 2 | +$9.57M | |
| 3 | +$5.75M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$5.4M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$4.68M |
Top Sellers
| 1 | -$7M | |
| 2 | -$5.29M | |
| 3 | -$5.28M | |
| 4 |
Morgan Stanley
New York
|
-$4.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.42M |